Chemotherapy induces ACE2 expression in breast cancer via the ROS-AKT-HIF-1α signaling pathway: a potential prognostic marker for breast cancer patients receiving chemotherapy

BACKGROUND: Angiotensin-converting enzyme 2 (ACE2) is a key enzyme of the renin-angiotensin system and a well-known functional receptor for the entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) into host cells. The COVID-19 pandemic has brought ACE2 into the spotlight, and ACE2 e...

Descripción completa

Detalles Bibliográficos
Autores principales: Zuo, Xiaoyan, Ren, Sixin, Zhang, He, Tian, Jianfei, Tian, Ruinan, Han, Baoai, Liu, Hui, Dong, Qian, Wang, Zhiyong, Cui, Yanfen, Niu, Ruifang, Zhang, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636712/
https://www.ncbi.nlm.nih.gov/pubmed/36335375
http://dx.doi.org/10.1186/s12967-022-03716-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636712/
https://www.ncbi.nlm.nih.gov/pubmed/36335375
http://dx.doi.org/10.1186/s12967-022-03716-w

Ejemplares similares